Page last updated: 2024-12-05

1-hydroxyanthraquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-Hydroxyanthraquinone is a natural anthraquinone derivative found in various plants, including Rubia tinctorum (madder), Aloe vera, and Cassia species. It exhibits a range of biological activities, including antioxidant, anti-inflammatory, anticancer, and antimicrobial properties. Its synthesis is achieved through various methods, including the oxidation of anthraquinone using reagents like chromic acid or potassium permanganate. 1-hydroxyanthraquinone has been studied extensively due to its potential therapeutic applications. Its antioxidant activity stems from its ability to scavenge free radicals and reduce oxidative stress, which may contribute to its anti-inflammatory and anticancer effects. It is also known to inhibit the growth of certain bacterial and fungal strains, suggesting potential antimicrobial uses. Further research is ongoing to explore its therapeutic potential and optimize its applications in various fields.'

Cross-References

ID SourceID
PubMed CID8512
CHEMBL ID501834
CHEBI ID28877
SCHEMBL ID145303
MeSH IDM0169777

Synonyms (58)

Synonym
1-hydroxyanthrachinon
anthraquinone, 1-hydroxy-
wln: l c666 bv ivj dq
nsc8640
1-hydroxy-9,10-anthraquinone
9, 1-hydroxy-
nsc-8640
nsc 8640
hsdb 7145
ccris 3694
brn 1912751
einecs 204-946-7
1-hydroxyanthrachinon [czech]
CHEBI:28877 ,
alpha-hydroxyanthraquinone
1-hydroxyanthracene-9,10-dione
CBDIVE_013840
9,10-anthracenedione, 1-hydroxy-
inchi=1/c14h8o3/c15-11-7-3-6-10-12(11)14(17)9-5-2-1-4-8(9)13(10)16/h1-7,15
1-hydroxyanthra-9,10-quinone
C02980
129-43-1
hydroxyanthraquinone
1-hydroxyanthraquinone
CHEMBL501834
H0354
A805939
1-hydroxyanthracene-9,10-dione;1-hydroxyanthraquinone
1-hydroxy-anthracene-9,10-dione
1-hydroxy anthraquinone
unii-lfu129oe9h
lfu129oe9h ,
1-hydroxy-9,10-anthracenedione
AKOS015856426
SCHEMBL145303
erythroxyanthraquinone
1-hydroxyanthraquinone [iarc]
.alpha.-hydroxyanthraquinone
1-hydroxyanthraquinone [hsdb]
4-hydroxyanthraquinone
1-hydroxyanthra-9,10-quinone #
W-108363
DTXSID1020722
1-hydroxyanthra-9,10-quinone, aldrichcpr
CS-W000838
bdbm50025501
mfcd00058946
1-hydroxy-9,10-dihydroanthracene-9,10-dione
GS-3366
9-hydroxy-1,10-anthraquinone
FT-0730299
SY052323
Q27103937
1-hydroxy-anthraquinone
O10414
hydroxyanthraquinone, 1-
HY-W000838
PD133665
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monohydroxyanthraquinoneAn anthraquinone in which the anthraquinone moiety is substituted by a single hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID358174Inhibition of p56 lck1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID343962Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.17)18.7374
1990's12 (50.00)18.2507
2000's5 (20.83)29.6817
2010's2 (8.33)24.3611
2020's4 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.58 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index5.57 (4.65)
Search Engine Demand Index36.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]